Cyclopia extracts act as selective estrogen receptor subtype downregulators in estrogen receptor positive breast cancer cell lines: Comparison to standard of care breast cancer endocrine therapies and a selective estrogen receptor agonist and antagonist
Breast cancer is the most diagnosed type of cancer amongst women in economically developing countries and globally. Most breast cancers express estrogen receptor alpha (ERα) and are categorized as positive (ER+) breast cancer. Endocrine therapies such as, selective estrogen receptor modulators (SERM...
Saved in:
Main Authors: | Folasade R. Olayoku (Author), Nicolette J. D. Verhoog (Author), Ann Louw (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of estrogen receptor coregulators in endocrine resistant breast cancer
by: Kristin A. Altwegg, et al.
Published: (2021) -
Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer
by: Yubo Wang, et al.
Published: (2023) -
The role of estrogen receptor beta in breast cancer
by: Yujing Zhou, et al.
Published: (2020) -
The Role of Selective Estrogen Receptor Modulators on Breast Cancer: From Tamoxifen to Raloxifene
by: Wen-Ling Lee, et al.
Published: (2008) -
Schisandrol A Exhibits Estrogenic Activity via Estrogen Receptor α-Dependent Signaling Pathway in Estrogen Receptor-Positive Breast Cancer Cells
by: Dahae Lee, et al.
Published: (2021)